USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
YUMA THERAPEUTICS CORPORATION
Address:
1770 Massachusetts Avenue, Suite 170
Cambridge, MA 02140-
Phone:
N/A
URL:
N/A
EIN:
190050648
DUNS:
831491571
Number of Employees:
N/A
Woman-Owned?:
Yes
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $200,752.00 1

Award List:

CSF Tau Biomarker-guided Development of Hsp90 Inhibitors for Alzheimer's Disease

Award Year / Program / Phase:
2012 / STTR / Phase I
Award Amount:
$200,752.00
Agency:
HHS
Principal Investigator:
Yukari Perrella – 617-953-4618
Research Institution:
BRIGHAM AND WOMEN'S HOSPITAL
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Research and Related Other Project Information Item 7. Project Summary/Abstract Neurodegeneration in Alzheimer's disease (AD) may result from deposition of A as plaques in brain tissue. However, less effort has been made to elucidate the role of tau-… More